Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization

F E Coenjaerts1, A M Walenkamp, P N Mwinzi

  • 1Division Infectious Diseases and AIDS, Department of Medicine, University Medical Center, 3508 GA Utrecht, The Netherlands. f.e.j.coenjaerts@lab.azu.nl

Insights

Cryptococcal mannoprotein (MP)-4, a novel capsular antigen, prematurely activates neutrophils. This desensitizes them to chemoattractants, explaining low neutrophil counts in cryptococcal meningitis.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Cryptococcal capsular antigens (Ags) trigger proinflammatory cytokines in cryptococcal meningitis.
  • Despite inflammation, cerebrospinal fluid (CSF) in these patients typically shows low neutrophil counts.
  • Capsular glucuronoxylomannan is hypothesized to inhibit neutrophil extravasation.

Purpose of the Study:

  • To identify the specific cryptococcal capsular antigen responsible for inhibiting neutrophil migration.
  • To elucidate the mechanism by which this antigen affects neutrophil function.
  • To determine the presence of this antigen in patient serum and CSF.

Main Methods:

  • Compared the effect of culture supernatant from wild-type and glucuronoxylomannan-deficient cryptococcal strains on neutrophil migration.
  • Purified and tested the inhibitory effect of capsular mannoprotein (MP)-4 on neutrophil migration towards various chemoattractants.
  • Investigated MP-4's mechanism of action using calcium (Ca2+) imaging and assessed changes in neutrophil surface receptor expression (L-selectin, TNF receptors, CD11b/18).
  • Detected MP-4 in serum and CSF from patients with cryptococcal meningitis.

Main Results:

  • Culture supernatant from a nonglucuronoxylomannan-producing strain inhibited neutrophil migration similarly to wild-type strains.
  • Purified capsular mannoprotein (MP)-4 inhibited neutrophil migration towards platelet-activating factor, IL-8, and fMLP.
  • MP-4 demonstrated chemotactic activity, suggesting chemoattractant receptor cross-desensitization.
  • MP-4 induced Ca2+ transients, decreased L-selectin, and increased CD11b/18 expression, while shedding TNF receptors.
  • MP-4 was detected in the serum and CSF of patients with cryptococcal meningitis.

Conclusions:

  • Capsular mannoprotein (MP)-4 is identified as a novel cryptococcal antigen.
  • MP-4 prematurely activates neutrophils, leading to desensitization towards chemoattractant challenges.
  • This mechanism likely contributes to the low neutrophil counts observed in the CSF of cryptococcal meningitis patients.